Definium Therapeutics, Inc. Interest Expense
Definium Therapeutics, Inc. (DFTX) reported Interest Expense of $1.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-06
- Definium Therapeutics, Inc. interest expense for the quarter ending 2026-06-30 was $1.23M, a 47.26% decline year-over-year.
- Definium Therapeutics, Inc. interest expense for the quarter ending 2026-03-31 was $1.25M, a 106.81% increase year-over-year.
- Definium Therapeutics, Inc. interest expense for the quarter ending 2025-12-31 was $1.27M, a 93.29% increase year-over-year.
- Definium Therapeutics, Inc. interest expense for the quarter ending 2025-09-30 was $1.27M, a 75.24% increase year-over-year.
- Definium Therapeutics, Inc. interest expense for fiscal 2025 was $5.48M, a 140.12% increase from fiscal 2024.
- Definium Therapeutics, Inc. interest expense for fiscal 2024 was $2.28M, a 148.15% increase from fiscal 2023.
- Definium Therapeutics, Inc. interest expense for fiscal 2023 was $920.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.23M 10-Q · filed 2026-08-06 | $2.48M 10-Q · filed 2026-08-06 | $3.75M derived: sum of 3 quarters · filed 2026-08-06 | $5.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-07 | $2.51M derived: sum of 2 quarters · filed 2026-05-07 | $3.79M derived: sum of 3 quarters · filed 2026-05-07 | $6.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.54M derived: sum of 2 quarters · filed 2026-02-26 | $4.88M derived: sum of 3 quarters · filed 2026-08-06 | $5.48M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-06 | $3.61M derived: sum of 2 quarters · filed 2026-08-06 | $4.21M 10-Q · filed 2025-11-06 | $4.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.34M 10-Q · filed 2026-08-06 | $2.94M 10-Q · filed 2026-08-06 | $3.60M derived: sum of 3 quarters · filed 2026-08-06 | $4.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $602.00K 10-Q · filed 2026-05-07 | $1.26M derived: sum of 2 quarters · filed 2026-05-07 | $1.99M derived: sum of 3 quarters · filed 2026-05-07 | $2.45M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $656.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.38M derived: sum of 2 quarters · filed 2026-02-26 | $1.85M derived: sum of 3 quarters · filed 2026-02-26 | $2.28M 10-K · filed 2026-02-26 |
| 2024-09-30 | $727.00K 10-Q · filed 2025-11-06 | $1.19M derived: sum of 2 quarters · filed 2025-11-06 | $1.63M 10-Q · filed 2025-11-06 | $2.07M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $466.00K 10-Q · filed 2025-07-31 | $900.00K 10-Q · filed 2025-07-31 | $1.34M derived: sum of 3 quarters · filed 2025-07-31 | $1.67M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $434.00K 10-Q · filed 2025-05-08 | $873.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.20M derived: sum of 3 quarters · filed 2025-05-08 | $1.28M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $767.00K derived: sum of 2 quarters · filed 2025-03-06 | $844.00K derived: sum of 3 quarters · filed 2025-03-06 | $920.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $328.00K 10-Q · filed 2024-11-07 | $405.00K derived: sum of 2 quarters · filed 2024-11-07 | $481.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $77.00K 10-Q · filed 2024-08-13 | $153.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $76.00K 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |